DNA Targeting Sequence Improves Magnetic Nanoparticle-Based Plasmid DNA Transfection Efficiency in Model Neurons

Area of Science:

• Biotechnology
• Molecular Biology
• Neuroscience

Background:

• Efficient non-viral plasmid DNA (pDNA) transfection is crucial for gene therapy research but remains challenging for stem cells and primary cell lines.
• Magnetic nanoparticle (MNP)-based DNA transfection offers improved efficiency and cell viability compared to other non-viral methods.
• Previous advancements include oscillating magnet arrays and optimization of MNP functionalization and transfection parameters.

Purpose of the Study:

• To investigate the impact of incorporating a DNA targeting sequence (DTS) into plasmid DNA for enhanced nuclear translocation during magnetic nanoparticle-mediated transfection.
• To evaluate the efficacy of DTS-modified pDNA in improving transfection efficiency in model neurons, including both dividing and non-dividing cell types.

Main Methods:

• Utilized magnetic nanoparticle-based DNA transfection with oscillating magnet arrays.
• Engineered plasmid DNA constructs incorporating a DNA targeting sequence (DTS).
• Compared transfection efficiency in dividing (SH-SY5Y precursor) and non-dividing (differentiated SH-SY5Y neuroblastoma) neuronal cells.

Main Results:

• Incorporation of the DTS feature in transfecting plasmid DNA significantly improved transfection efficiency in model neurons.
• The enhancement in transfection was particularly evident in non-dividing, differentiated SH-SY5Y neuroblastoma cells compared to dividing precursor cells.
• This suggests that the DTS facilitates improved nuclear translocation of the delivered pDNA.

Conclusions:

• The DNA targeting sequence (DTS) is a valuable addition to plasmid DNA for improving non-viral gene delivery, especially in challenging cell types like differentiated neurons.
• This strategy addresses the limitation of nuclear translocation in magnetic nanoparticle-mediated transfection.
• The findings support the potential of DTS-modified pDNA for advancing gene therapy applications in neuroscience.